Click for best price
Remicade Biosimilar Market Size, Share 2024
This research report provides a comprehensive analysis of the Remicade Biosimilar market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Remicade Biosimilar market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Remicade Biosimilar, challenges faced by the industry, and potential opportunities for market players.
The global Remicade Biosimilar market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Remicade Biosimilar market presents opportunities for various stakeholders, including Blood Disorders, Oncology Diseases. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Remicade Biosimilar market. Additionally, the growing consumer demand present avenues for market expansion.
The global Remicade Biosimilar market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The market for Remicade biosimilars is driven by the increasing demand for cost-effective biologic therapies and the expiration of Remicade's patent, leading to the entry of biosimilar competitors. The market's growth is also influenced by regulatory support for biosimilars and the ongoing development of new biologic therapies.
Key Features:
The research report on the Remicade Biosimilar market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Remicade Biosimilar market.
Market Overview: The report provides a comprehensive overview of the Remicade Biosimilar market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 100mg/10ml, 500mg/50ml), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Remicade Biosimilar market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Remicade Biosimilar market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Remicade Biosimilar market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Remicade Biosimilar market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Remicade Biosimilar market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Remicade Biosimilar market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Remicade Biosimilar, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Remicade Biosimilar market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Remicade Biosimilar market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
100mg/10ml
500mg/50ml
Market segment by Application
Blood Disorders
Oncology Diseases
Global Remicade Biosimilar Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Fosun Pharmaceutical
Livzon Pharmaceutical
Anke Biotechnology
Hualan Biological Engineering
Walvax Biotechnology
Hisun Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Remicade Biosimilar, market overview.
Chapter 2: Global Remicade Biosimilar market size in revenue and volume.
Chapter 3: Detailed analysis of Remicade Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Remicade Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Remicade Biosimilar capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Remicade Biosimilar Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
139 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Remicade Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Remicade Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Remicade Biosimilar Overall Market Size
2.1 Global Remicade Biosimilar Market Size: 2023 VS 2030
2.2 Global Remicade Biosimilar Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Remicade Biosimilar Sales: 2019-2030
3 Company Landscape
3.1 Top Remicade Biosimilar Players in Global Market
3.2 Top Global Remicade Biosimilar Companies Ranked by Revenue
3.3 Global Remicade Biosimilar Revenue by Companies
3.4 Global Remicade Biosimilar Sales by Companies
3.5 Global Remicade Biosimilar Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Remicade Biosimilar Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Remicade Biosimilar Product Type
3.8 Tier 1, Tier 2 and Tier 3 Remicade Biosimilar Players in Global Market
3.8.1 List of Global Tier 1 Remicade Biosimilar Companies
3.8.2 List of Global Tier 2 and Tier 3 Remicade Biosimilar Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Remicade Biosimilar Market Size Markets, 2023 & 2030
4.1.2 100mg/10ml
4.1.3 500mg/50ml
4.2 By Type - Global Remicade Biosimilar Revenue & Forecasts
4.2.1 By Type - Global Remicade Biosimilar Revenue, 2019-2024
4.2.2 By Type - Global Remicade Biosimilar Revenue, 2025-2030
4.2.3 By Type - Global Remicade Biosimilar Revenue Market Share, 2019-2030
4.3 By Type - Global Remicade Biosimilar Sales & Forecasts
4.3.1 By Type - Global Remicade Biosimilar Sales, 2019-2024
4.3.2 By Type - Global Remicade Biosimilar Sales, 2025-2030
4.3.3 By Type - Global Remicade Biosimilar Sales Market Share, 2019-2030
4.4 By Type - Global Remicade Biosimilar Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Remicade Biosimilar Market Size, 2023 & 2030
5.1.2 Blood Disorders
5.1.3 Oncology Diseases
5.2 By Application - Global Remicade Biosimilar Revenue & Forecasts
5.2.1 By Application - Global Remicade Biosimilar Revenue, 2019-2024
5.2.2 By Application - Global Remicade Biosimilar Revenue, 2025-2030
5.2.3 By Application - Global Remicade Biosimilar Revenue Market Share, 2019-2030
5.3 By Application - Global Remicade Biosimilar Sales & Forecasts
5.3.1 By Application - Global Remicade Biosimilar Sales, 2019-2024
5.3.2 By Application - Global Remicade Biosimilar Sales, 2025-2030
5.3.3 By Application - Global Remicade Biosimilar Sales Market Share, 2019-2030
5.4 By Application - Global Remicade Biosimilar Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Remicade Biosimilar Market Size, 2023 & 2030
6.2 By Region - Global Remicade Biosimilar Revenue & Forecasts
6.2.1 By Region - Global Remicade Biosimilar Revenue, 2019-2024
6.2.2 By Region - Global Remicade Biosimilar Revenue, 2025-2030
6.2.3 By Region - Global Remicade Biosimilar Revenue Market Share, 2019-2030
6.3 By Region - Global Remicade Biosimilar Sales & Forecasts
6.3.1 By Region - Global Remicade Biosimilar Sales, 2019-2024
6.3.2 By Region - Global Remicade Biosimilar Sales, 2025-2030
6.3.3 By Region - Global Remicade Biosimilar Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Remicade Biosimilar Revenue, 2019-2030
6.4.2 By Country - North America Remicade Biosimilar Sales, 2019-2030
6.4.3 US Remicade Biosimilar Market Size, 2019-2030
6.4.4 Canada Remicade Biosimilar Market Size, 2019-2030
6.4.5 Mexico Remicade Biosimilar Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Remicade Biosimilar Revenue, 2019-2030
6.5.2 By Country - Europe Remicade Biosimilar Sales, 2019-2030
6.5.3 Germany Remicade Biosimilar Market Size, 2019-2030
6.5.4 France Remicade Biosimilar Market Size, 2019-2030
6.5.5 U.K. Remicade Biosimilar Market Size, 2019-2030
6.5.6 Italy Remicade Biosimilar Market Size, 2019-2030
6.5.7 Russia Remicade Biosimilar Market Size, 2019-2030
6.5.8 Nordic Countries Remicade Biosimilar Market Size, 2019-2030
6.5.9 Benelux Remicade Biosimilar Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Remicade Biosimilar Revenue, 2019-2030
6.6.2 By Region - Asia Remicade Biosimilar Sales, 2019-2030
6.6.3 China Remicade Biosimilar Market Size, 2019-2030
6.6.4 Japan Remicade Biosimilar Market Size, 2019-2030
6.6.5 South Korea Remicade Biosimilar Market Size, 2019-2030
6.6.6 Southeast Asia Remicade Biosimilar Market Size, 2019-2030
6.6.7 India Remicade Biosimilar Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Remicade Biosimilar Revenue, 2019-2030
6.7.2 By Country - South America Remicade Biosimilar Sales, 2019-2030
6.7.3 Brazil Remicade Biosimilar Market Size, 2019-2030
6.7.4 Argentina Remicade Biosimilar Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Remicade Biosimilar Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Remicade Biosimilar Sales, 2019-2030
6.8.3 Turkey Remicade Biosimilar Market Size, 2019-2030
6.8.4 Israel Remicade Biosimilar Market Size, 2019-2030
6.8.5 Saudi Arabia Remicade Biosimilar Market Size, 2019-2030
6.8.6 UAE Remicade Biosimilar Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Synthon Pharmaceuticals
7.1.1 Synthon Pharmaceuticals Company Summary
7.1.2 Synthon Pharmaceuticals Business Overview
7.1.3 Synthon Pharmaceuticals Remicade Biosimilar Major Product Offerings
7.1.4 Synthon Pharmaceuticals Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.1.5 Synthon Pharmaceuticals Key News & Latest Developments
7.2 LG Life Sciences
7.2.1 LG Life Sciences Company Summary
7.2.2 LG Life Sciences Business Overview
7.2.3 LG Life Sciences Remicade Biosimilar Major Product Offerings
7.2.4 LG Life Sciences Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.2.5 LG Life Sciences Key News & Latest Developments
7.3 Novartis (Sandoz)
7.3.1 Novartis (Sandoz) Company Summary
7.3.2 Novartis (Sandoz) Business Overview
7.3.3 Novartis (Sandoz) Remicade Biosimilar Major Product Offerings
7.3.4 Novartis (Sandoz) Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.3.5 Novartis (Sandoz) Key News & Latest Developments
7.4 Celltrion
7.4.1 Celltrion Company Summary
7.4.2 Celltrion Business Overview
7.4.3 Celltrion Remicade Biosimilar Major Product Offerings
7.4.4 Celltrion Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.4.5 Celltrion Key News & Latest Developments
7.5 Biocon
7.5.1 Biocon Company Summary
7.5.2 Biocon Business Overview
7.5.3 Biocon Remicade Biosimilar Major Product Offerings
7.5.4 Biocon Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.5.5 Biocon Key News & Latest Developments
7.6 Hospira
7.6.1 Hospira Company Summary
7.6.2 Hospira Business Overview
7.6.3 Hospira Remicade Biosimilar Major Product Offerings
7.6.4 Hospira Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.6.5 Hospira Key News & Latest Developments
7.7 Merck Serono (Merck Group)
7.7.1 Merck Serono (Merck Group) Company Summary
7.7.2 Merck Serono (Merck Group) Business Overview
7.7.3 Merck Serono (Merck Group) Remicade Biosimilar Major Product Offerings
7.7.4 Merck Serono (Merck Group) Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.7.5 Merck Serono (Merck Group) Key News & Latest Developments
7.8 Biogen idec Inc.
7.8.1 Biogen idec Inc. Company Summary
7.8.2 Biogen idec Inc. Business Overview
7.8.3 Biogen idec Inc. Remicade Biosimilar Major Product Offerings
7.8.4 Biogen idec Inc. Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.8.5 Biogen idec Inc. Key News & Latest Developments
7.9 Genentech (Roche Group)
7.9.1 Genentech (Roche Group) Company Summary
7.9.2 Genentech (Roche Group) Business Overview
7.9.3 Genentech (Roche Group) Remicade Biosimilar Major Product Offerings
7.9.4 Genentech (Roche Group) Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.9.5 Genentech (Roche Group) Key News & Latest Developments
7.10 Fosun Pharmaceutical
7.10.1 Fosun Pharmaceutical Company Summary
7.10.2 Fosun Pharmaceutical Business Overview
7.10.3 Fosun Pharmaceutical Remicade Biosimilar Major Product Offerings
7.10.4 Fosun Pharmaceutical Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.10.5 Fosun Pharmaceutical Key News & Latest Developments
7.11 Livzon Pharmaceutical
7.11.1 Livzon Pharmaceutical Company Summary
7.11.2 Livzon Pharmaceutical Business Overview
7.11.3 Livzon Pharmaceutical Remicade Biosimilar Major Product Offerings
7.11.4 Livzon Pharmaceutical Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.11.5 Livzon Pharmaceutical Key News & Latest Developments
7.12 Anke Biotechnology
7.12.1 Anke Biotechnology Company Summary
7.12.2 Anke Biotechnology Business Overview
7.12.3 Anke Biotechnology Remicade Biosimilar Major Product Offerings
7.12.4 Anke Biotechnology Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.12.5 Anke Biotechnology Key News & Latest Developments
7.13 Hualan Biological Engineering
7.13.1 Hualan Biological Engineering Company Summary
7.13.2 Hualan Biological Engineering Business Overview
7.13.3 Hualan Biological Engineering Remicade Biosimilar Major Product Offerings
7.13.4 Hualan Biological Engineering Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.13.5 Hualan Biological Engineering Key News & Latest Developments
7.14 Walvax Biotechnology
7.14.1 Walvax Biotechnology Company Summary
7.14.2 Walvax Biotechnology Business Overview
7.14.3 Walvax Biotechnology Remicade Biosimilar Major Product Offerings
7.14.4 Walvax Biotechnology Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.14.5 Walvax Biotechnology Key News & Latest Developments
7.15 Hisun Pharmaceutical
7.15.1 Hisun Pharmaceutical Company Summary
7.15.2 Hisun Pharmaceutical Business Overview
7.15.3 Hisun Pharmaceutical Remicade Biosimilar Major Product Offerings
7.15.4 Hisun Pharmaceutical Remicade Biosimilar Sales and Revenue in Global (2019-2024)
7.15.5 Hisun Pharmaceutical Key News & Latest Developments
8 Global Remicade Biosimilar Production Capacity, Analysis
8.1 Global Remicade Biosimilar Production Capacity, 2019-2030
8.2 Remicade Biosimilar Production Capacity of Key Manufacturers in Global Market
8.3 Global Remicade Biosimilar Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Remicade Biosimilar Supply Chain Analysis
10.1 Remicade Biosimilar Industry Value Chain
10.2 Remicade Biosimilar Upstream Market
10.3 Remicade Biosimilar Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Remicade Biosimilar Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Remicade Biosimilar in Global Market
Table 2. Top Remicade Biosimilar Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Remicade Biosimilar Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Remicade Biosimilar Revenue Share by Companies, 2019-2024
Table 5. Global Remicade Biosimilar Sales by Companies, (L), 2019-2024
Table 6. Global Remicade Biosimilar Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Remicade Biosimilar Price (2019-2024) & (US$/Ml)
Table 8. Global Manufacturers Remicade Biosimilar Product Type
Table 9. List of Global Tier 1 Remicade Biosimilar Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Remicade Biosimilar Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Remicade Biosimilar Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Remicade Biosimilar Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Remicade Biosimilar Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Remicade Biosimilar Sales (L), 2019-2024
Table 15. By Type - Global Remicade Biosimilar Sales (L), 2025-2030
Table 16. By Application ? Global Remicade Biosimilar Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Remicade Biosimilar Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Remicade Biosimilar Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Remicade Biosimilar Sales (L), 2019-2024
Table 20. By Application - Global Remicade Biosimilar Sales (L), 2025-2030
Table 21. By Region ? Global Remicade Biosimilar Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Remicade Biosimilar Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Remicade Biosimilar Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Remicade Biosimilar Sales (L), 2019-2024
Table 25. By Region - Global Remicade Biosimilar Sales (L), 2025-2030
Table 26. By Country - North America Remicade Biosimilar Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Remicade Biosimilar Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Remicade Biosimilar Sales, (L), 2019-2024
Table 29. By Country - North America Remicade Biosimilar Sales, (L), 2025-2030
Table 30. By Country - Europe Remicade Biosimilar Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Remicade Biosimilar Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Remicade Biosimilar Sales, (L), 2019-2024
Table 33. By Country - Europe Remicade Biosimilar Sales, (L), 2025-2030
Table 34. By Region - Asia Remicade Biosimilar Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Remicade Biosimilar Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Remicade Biosimilar Sales, (L), 2019-2024
Table 37. By Region - Asia Remicade Biosimilar Sales, (L), 2025-2030
Table 38. By Country - South America Remicade Biosimilar Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Remicade Biosimilar Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Remicade Biosimilar Sales, (L), 2019-2024
Table 41. By Country - South America Remicade Biosimilar Sales, (L), 2025-2030
Table 42. By Country - Middle East & Africa Remicade Biosimilar Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Remicade Biosimilar Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Remicade Biosimilar Sales, (L), 2019-2024
Table 45. By Country - Middle East & Africa Remicade Biosimilar Sales, (L), 2025-2030
Table 46. Synthon Pharmaceuticals Company Summary
Table 47. Synthon Pharmaceuticals Remicade Biosimilar Product Offerings
Table 48. Synthon Pharmaceuticals Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 49. Synthon Pharmaceuticals Key News & Latest Developments
Table 50. LG Life Sciences Company Summary
Table 51. LG Life Sciences Remicade Biosimilar Product Offerings
Table 52. LG Life Sciences Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 53. LG Life Sciences Key News & Latest Developments
Table 54. Novartis (Sandoz) Company Summary
Table 55. Novartis (Sandoz) Remicade Biosimilar Product Offerings
Table 56. Novartis (Sandoz) Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 57. Novartis (Sandoz) Key News & Latest Developments
Table 58. Celltrion Company Summary
Table 59. Celltrion Remicade Biosimilar Product Offerings
Table 60. Celltrion Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 61. Celltrion Key News & Latest Developments
Table 62. Biocon Company Summary
Table 63. Biocon Remicade Biosimilar Product Offerings
Table 64. Biocon Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 65. Biocon Key News & Latest Developments
Table 66. Hospira Company Summary
Table 67. Hospira Remicade Biosimilar Product Offerings
Table 68. Hospira Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 69. Hospira Key News & Latest Developments
Table 70. Merck Serono (Merck Group) Company Summary
Table 71. Merck Serono (Merck Group) Remicade Biosimilar Product Offerings
Table 72. Merck Serono (Merck Group) Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 73. Merck Serono (Merck Group) Key News & Latest Developments
Table 74. Biogen idec Inc. Company Summary
Table 75. Biogen idec Inc. Remicade Biosimilar Product Offerings
Table 76. Biogen idec Inc. Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 77. Biogen idec Inc. Key News & Latest Developments
Table 78. Genentech (Roche Group) Company Summary
Table 79. Genentech (Roche Group) Remicade Biosimilar Product Offerings
Table 80. Genentech (Roche Group) Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 81. Genentech (Roche Group) Key News & Latest Developments
Table 82. Fosun Pharmaceutical Company Summary
Table 83. Fosun Pharmaceutical Remicade Biosimilar Product Offerings
Table 84. Fosun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 85. Fosun Pharmaceutical Key News & Latest Developments
Table 86. Livzon Pharmaceutical Company Summary
Table 87. Livzon Pharmaceutical Remicade Biosimilar Product Offerings
Table 88. Livzon Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 89. Livzon Pharmaceutical Key News & Latest Developments
Table 90. Anke Biotechnology Company Summary
Table 91. Anke Biotechnology Remicade Biosimilar Product Offerings
Table 92. Anke Biotechnology Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 93. Anke Biotechnology Key News & Latest Developments
Table 94. Hualan Biological Engineering Company Summary
Table 95. Hualan Biological Engineering Remicade Biosimilar Product Offerings
Table 96. Hualan Biological Engineering Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 97. Hualan Biological Engineering Key News & Latest Developments
Table 98. Walvax Biotechnology Company Summary
Table 99. Walvax Biotechnology Remicade Biosimilar Product Offerings
Table 100. Walvax Biotechnology Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 101. Walvax Biotechnology Key News & Latest Developments
Table 102. Hisun Pharmaceutical Company Summary
Table 103. Hisun Pharmaceutical Remicade Biosimilar Product Offerings
Table 104. Hisun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$, Mn) and Average Price (US$/Ml) (2019-2024)
Table 105. Hisun Pharmaceutical Key News & Latest Developments
Table 106. Remicade Biosimilar Production Capacity (L) of Key Manufacturers in Global Market, 2022-2024 (L)
Table 107. Global Remicade Biosimilar Capacity Market Share of Key Manufacturers, 2022-2024
Table 108. Global Remicade Biosimilar Production by Region, 2019-2024 (L)
Table 109. Global Remicade Biosimilar Production by Region, 2025-2030 (L)
Table 110. Remicade Biosimilar Market Opportunities & Trends in Global Market
Table 111. Remicade Biosimilar Market Drivers in Global Market
Table 112. Remicade Biosimilar Market Restraints in Global Market
Table 113. Remicade Biosimilar Raw Materials
Table 114. Remicade Biosimilar Raw Materials Suppliers in Global Market
Table 115. Typical Remicade Biosimilar Downstream
Table 116. Remicade Biosimilar Downstream Clients in Global Market
Table 117. Remicade Biosimilar Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Remicade Biosimilar Segment by Type in 2023
Figure 2. Remicade Biosimilar Segment by Application in 2023
Figure 3. Global Remicade Biosimilar Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Remicade Biosimilar Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Remicade Biosimilar Revenue, 2019-2030 (US$, Mn)
Figure 7. Remicade Biosimilar Sales in Global Market: 2019-2030 (L)
Figure 8. The Top 3 and 5 Players Market Share by Remicade Biosimilar Revenue in 2023
Figure 9. By Type - Global Remicade Biosimilar Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Remicade Biosimilar Revenue Market Share, 2019-2030
Figure 11. By Type - Global Remicade Biosimilar Sales Market Share, 2019-2030
Figure 12. By Type - Global Remicade Biosimilar Price (US$/Ml), 2019-2030
Figure 13. By Application - Global Remicade Biosimilar Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Remicade Biosimilar Revenue Market Share, 2019-2030
Figure 15. By Application - Global Remicade Biosimilar Sales Market Share, 2019-2030
Figure 16. By Application - Global Remicade Biosimilar Price (US$/Ml), 2019-2030
Figure 17. By Region - Global Remicade Biosimilar Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Remicade Biosimilar Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Remicade Biosimilar Revenue Market Share, 2019-2030
Figure 20. By Region - Global Remicade Biosimilar Sales Market Share, 2019-2030
Figure 21. By Country - North America Remicade Biosimilar Revenue Market Share, 2019-2030
Figure 22. By Country - North America Remicade Biosimilar Sales Market Share, 2019-2030
Figure 23. US Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Remicade Biosimilar Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Remicade Biosimilar Sales Market Share, 2019-2030
Figure 28. Germany Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 29. France Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Remicade Biosimilar Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Remicade Biosimilar Sales Market Share, 2019-2030
Figure 37. China Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 41. India Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Remicade Biosimilar Revenue Market Share, 2019-2030
Figure 43. By Country - South America Remicade Biosimilar Sales Market Share, 2019-2030
Figure 44. Brazil Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Remicade Biosimilar Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Remicade Biosimilar Sales Market Share, 2019-2030
Figure 48. Turkey Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Remicade Biosimilar Revenue, (US$, Mn), 2019-2030
Figure 52. Global Remicade Biosimilar Production Capacity (L), 2019-2030
Figure 53. The Percentage of Production Remicade Biosimilar by Region, 2023 VS 2030
Figure 54. Remicade Biosimilar Industry Value Chain
Figure 55. Marketing Channels
